TrialFrontiers in immunology2023

Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial.

Jun Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.